Search

Trouble comes from where investors least expect it, so it’s not surprising to us that the Russia-Ukraine situation is making investors nervous. Is there a chance this is the event that capsizes the market? Of course there is—and that’s why you should watch your stops and risk. But after such a powerful rally for much of February among the major indexes and many stocks, the odds favor the first dip being buyable, at least among leading stocks. That doesn’t mean the pullback can’t last a few days (news-driven ups and downs are likely in the short-term), but with the overall uptrend intact, we remain optimistic.

This week’s list isn’t as growth-oriented as the past few weeks, but there are still more than a few good stories here. Our Top Pick is Avis Budget (CAR), a well-known firm with surprisingly solid earnings growth prospects as global travel increases.

Stock Name	Price	Buy Range	Loss Limit
58.com (WUBA)	0.00	46-48	41-42
Trimble Navigation (TRMB)	0.00	36-38	34-35
Signet Jewelers (SIG)	0.00	93-95	85-87
Spirit Airlines (SAVE)	57.03	54-57	49.5-50.5
Regeneron Pharmaceuticals (REGN)	512.96	320-330	275-280
Penn Virginia (PVA)	0.00	14-14.5	12-12.5
Michael Kors Holdings Limited (KORS)	73.22	95-100	85-90
Keurig Green Mountain (GMCR)	0.00	105-112	91-92
Avis Budget Group (CAR)	0.00	45-47	41-42
Basic Energy Services (BAS)	0.00	21.5-23	19-20

The evidence has generally improved during the past two weeks, with the major indexes remaining in solid uptrends and, most encouragingly, more growth-oriented stocks showing power and emerging from basing structures. All of that is to the good, but earnings season is ramping up, and we know that can change any stock’s or sector’s outlook in a hurry. Put it together, and we’re still sticking with our lean bullish stance—now’s probably not the time to buy five or six stocks at once, but there are many attractive names out there, and getting in at opportune times should pay off.

This week’s list is heavy on growth stocks, though there are a couple of cyclical and special situation ideas, too. Our favorite of the week is HomeAway (AWAY), a firm we remain keen on, and a stock that’s testing support for the first time since a powerful November breakout.

Stock Name	Price	Buy Range	Loss Limit
T-Mobile US (TMUS)	0.00	30-32	27-28
SolarCity (SCTY)	0.00	70-74	63-64
Altisource Residential (RESI)	0.00	31.5-33	29-29.5
Pacira Biosiences (PCRX)	54.85	63-65	53-55
Palo Alto Networks (PANW)	236.92	60-62.5	55-56
The Manitowoc Company (MTW)	0.00	23.5-25	21.5-22
Harman International Industries, Inc. (HAR)	0.00	87-90	80-81
Forest Labs (FRX)	0.00	65-70	59-60
HomeAway, Inc. (AWAY)	0.00	40-42	37-37.5
AOL, Inc. (AOL)	0.00	48-50	44-45

It’s been a fun and fruitful 2013, and we hope you were able to snag a few winners this year. That said, while we enjoy reviewing this past year as much as anyone, our focus is on the present and the future—so far, the overall market is in fine shape, though intriguingly, despite what is supposed to be a quiet time of year, we’ve seen a few sharp selloffs among growth stocks during the past couple of days. Of course, there are always lots of crosscurrents at year-end, but it’s imperative to keep your eyes open, pick your spots on the buy side and have some stops in place should the selling spread. Right now, though, we’re sticking with our lean bullish stance and will see how things shake out when the calendar turns.
This week’s list is very diversified, with many different industries represented. Our favorite of the week is Salix Pharmaceuticals (SLXP), a solid growth firm whose recent buyout of Santarus could be a gamechanger.

Stock Name	Price	Buy Range	Loss Limit
United States Steel Corporation (X)	0.00	28-30	26-26.5
Valero Energy (VLO)	97.40	46-47	42-43
United Therapeutics (UTHR)	0.00	105-112	97-100
Seagate Technology (STX)	0.00	53-55	49-50
Salix Pharmaceuticals (SLXP)	0.00	86-90	81-82
Royal Caribbean Cruises (RCL)	0.00	45-47	39-40
NXP Semiconductors (NXPI)	0.00	43-45	40-41
Legg Mason Inc. (LM)	37.44	40-42	38-39
Facebook, Inc. (FB)	0.00	52.5-55.5	48-49
Conn’s Inc. (CONN)	0.00	74-78	68.5-69.5

After a straight-down move following the election, the market rallied smartly during Thanksgiving week on light volume. Clearly, the move was good to see, and there are a decent number of good-looking set-ups out there. However, by our measures, the market’s trends remain down, and we think the rubber will meet the road from this point forward—if the correction is over, we expect more and more stocks to shape up, and for the major indexes to build on their gains. If not, we expect the sellers to take advantage of these prices during the next few days. For now, remain cautious, and we’ll let you know if we get any new buy signals.

In the meantime, it’s imperative to be up on the best-acting stocks and sectors in the market. This week’s list has many names that are off most investors’ radar screens, which we like. Our favorite of the week is Salesforce.com (CRM), a big firm that looks ready to get going after a two-year pause.

Stock Name	Price	Buy Range	Loss Limit
Tenet Healthcare (THC)	0.00	26.5-27.5	-
Regeneron Pharmaceuticals (REGN)	512.96	163-170	-
Qihoo 360 (QIHU)	0.00	21-23	-
Packaging Corp (PKG)	0.00	35.5-37	-
HollyFrontier Corporation (HFC)	0.00	42-44	-
HDFC Bank Limited (HDB)	0.00	38-40	-
Gilead Sciences (GILD)	75.10	70-73	-
Eaton Vance Corp. (EV)	0.00	30-31.5	-
Salesforce.com (CRM)	0.00	155-162	-
Alaska Air Group (ALK)	0.00	40.5-42	-

Current Market Outlook


Since the March 23 low, the market has pretty much followed the plan, with a good initial rally, a little upside follow through and lots of up/down, news-driven moves since. To be fair, that is more descriptive than predictive—a few big moves in one direction or the other could change the outlook, and today’s action was encouraging for the bulls. Right now, though, the overall evidence remains unchanged: The trend of the major indexes and most stocks is still pointed down, and while many names are doing a good job of hanging in there, few stocks are in true uptrends. Looking ahead, the first sign of light would be a batch of growth-oriented stocks bursting to new highs, followed by the intermediate-term trend of the major indexes turning up (likely to take another week even if all goes well). Given the unprecedented situation, we’re open to anything, but until the buyers show more muscle, we advise sticking with a mostly defensive stance.

The good news is that we continue to see quite a few stocks that institutions have been accumulating in recent weeks. This week’s list has a few, with our Top Pick being Livongo (LVGO), a newer, fast-growing name that’s popped up of late.

Stock Name	Price	Buy Range	Loss Limit
Five9 (FIVN)	78.35	74.5-78	66-68
Livongo Health Inc. (LVGO)	33.34	27.5-30	23-24.5
Newmont Mining (NEM)	57.31	48-51	42.5-44.5
Novavax, Inc. (NVAX)	65.95	13-14.5	10.5-11.5
Peloton (PTON)	53.03	27-29	23-24.5
Pinduoduo (PDD)	87.53	36.5-38.5	33-34
Regeneron Pharmaceuticals (REGN)	512.96	470-490	415-425
RingCentral (RNG)	238.73	213-225	187-192
Sprouts Farmers Market (SFM)	19.00	18.5-19.5	16-16.5
Zscaler (ZS)	126.22	61-64	54-55.5

After huge runs during the past six months, the evidence of the past few weeks indicates that most growth stocks have topped for the intermediate-term; sure, things can always change during earnings season, but most of the “hot” growth stocks will likely need time to build new launching pads. The key going forward will be whether the selling in growth stocks spreads to the broad market—that hasn’t happened yet, and in fact, we’re seeing many quality set-ups (and a few real breakouts) among some cyclical-type stocks. It’s encouraging, but for now we’re content to watch and wait to see if selling spreads or if buyers return.

This week’s list features many resilient names in less-sexy industries that nevertheless still have great potential. Our favorite of the week is Diebold (DBD), an older tech player whose earnings should boom in the quarters ahead.

Stock Name	Price	Buy Range	Loss Limit
Domtar (UFS)	0.00	108-114	100-102
Under Armour (UA)	0.00	110-120	102-104
Tata Motors Limited (TTM)	0.00	32-34	29-30
US Silica Holdings, Inc. (SLCA)	0.00	34-36	31-32
Martin Marietta Materials (MLM)	261.52	123-126	112-115
Ingram Micro (IM)	0.00	28-29.5	26-27
Horizon Therapeutics (HZNP)	49.89	14-15.5	12-13
Diebold (DBD)	0.00	38-40	34-36
Comstock Resources (CRK)	0.00	21-22	19-19.5
Baker Hughes (BHI)	0.00	63-66	60-61

Last week we wrote that usually the first shakeout after a multi-week thrust isn’t the last, and indeed, we’ve seen some follow-on profit-taking among the market’s strongest stocks. There has been a little abnormal action here and there (mostly in biotech, but some elsewhere, too), but so far, the vast majority of stocks are simply pulling back after big-volume moves to new highs. If the selling spreads and the uptrend fails, then we’ll change our advice. But, as usual, we advise going with the weight of the evidence, which today remains bullish. Thus, hold your top performers, and adding a stock or two on dips is still favored.

This week’s list has a diverse flair to it—it’s not all high-flying stocks like we saw during February. But there is still plenty to like, including our Top Pick, Novo Nordisk (NVO), which has a solid growth story and a chart that’s at a fine entry point.

Stock Name	Price	Buy Range	Loss Limit
Under Armour (UA)	0.00	110-115	99-102
Trina Solar (TSL)	0.00	17-18	14-15
SouFun (SFUN)	0.00	88-90	78-80
Qihoo 360 (QIHU)	0.00	112-120	97-100
Novo Nordisk (NVO)	0.00	44.5-46.5	41-42
MasTec, Inc. (MTZ)	66.65	40-42	37-38
Magna International Inc. (MGA)	0.00	94-96.5	88-89
CoStar Group (CSGP)	589.55	200-208	182-185
Athenahealth (ATHN)	0.00	178-182	154-156
Alaska Air Group (ALK)	0.00	87-90	80-81

In the last issue we thought growth stocks could easily have a few hiccups, and that’s generally what we’ve seen, with many well-known, extended titles hitting some turbulence. And, looking at the entire market, it lost some steam over the past three weeks, with the news-driven selling of the past two days doing some damage.

Bigger picture, our views haven’t changed at all -- this is a bull market that’s likely to move meaningfully higher in the months ahead. We remain heavily invested (88% in the Model Portfolio), but we’re watching things closely to see if this is more of a shakeout or the start of a sustained selling wave.

In tonight’s issue we write about one sector that appears to be breaking free of very long launching pad, with most components doing the same. (Our favorite name in the sector reports earnings tonight.) And we also run through all of our stocks, sharing our thoughts on many of them pre- and post-earnings.

Growth stocks have changed character over the past week, with abnormal action and breakdowns appearing. The good news is that a major top doesn’t appear to be in place; the general market is still hanging in there for now, and the long-term trend of most leaders is still up. But, taking things on a stock-by-stock basis, we’ve pared back a bunch and are actually holding more than half the portfolio in cash. That’s probably too high (we’d like to put some to work in fresher leaders), but we’re content to patiently wait for buyers to support the market.

In tonight’s issue, we review all our stocks, dive into the two main factors to your investment returns and go over many fresher names that could help lead the market’s next upmove.

Thank you for subscribing to the Cabot Turnaround Letter. We hope you enjoy reading the September 30th issue.

This month we look at stocks that might benefit from the (eventual) arrival of a post-Covid world. Currently, the news seems uninspiring – new cases are accelerating in some regions that may foreshadow a return of economically-crippling lockdowns, and hopes are dimming for a vaccine in the near future.



Many stocks have surged already in anticipation of this yearned-for world, but many remain moribund. Some laggards are likely to be zombies – still alive but burdened with overwhelming debt loads. We avoided these, and instead found several that should prosper with the return of a fully-opened economy and also have more resilient capital structures to help them endure while we all wait.



We also looked at publicly-traded chicken processors and found that the sky is not actually falling, even if the shares seem to imply an atmospheric tumbling. Near-term wholesale chicken prices have become meaningfully but temporarily depressed, in our view. We highlight three stocks and discuss their risk/return nuances, along with a fourth intriguing commodity food company.



Our feature recommendation, Western Digital (WDC), trades at a depressed valuation but has major strategic changes underway.



The letter also includes a summary of our recent sale of Gilead Sciences (GILD) as well as the full roster of our current recommendations.



Please feel free to send me your questions and comments. This newsletter is written for you and a great way to get more out of your letter is to let me know what you are looking for.



I’m best reachable at Bruce@CabotWealth.com. I’ll do my best to respond as quickly as possible.



Thanks!

The Nasdaq and growth stocks have a lost a little steam since early July, with fewer stocks moving up and the indexes doing more chopping than trending. That’s a good reason to take your foot off the accelerator, but most of the big-picture evidence remains positive, so we’re holding our strong, profitable stocks and remaining mostly bullish.

In tonight’s issue, we review some of that bullish longer-term evidence, talk a bit about gold stocks and, as always, go over our latest thoughts on the stocks we own and are watching.

Current Market Outlook


It’s been six weeks since the market bottomed, and the evidence since then has steadily improved—whether it was the blast off from the lows (2-to-1 Blastoff Indicator), the lack of any sustained selling since, the amazing upside breadth or the increasing number of setups and breakouts among growth stocks, it’s all been going the bulls’ way. Of course, now that the market has basically marched ahead for six weeks, things could easily get trickier; even some intermediate-term measures (84% of NYSE stocks above their 50-day lines) are stretched. That’s no reason to worry (longer-term, such power is probably a good sign), but we’d be looking to buy mostly on dips, though we’re still interested in the occasional earnings breakout, too. And, as things head higher, don’t forget to book some partial profits along the way. We’re bumping up our Market Monitor another notch tonight.
This week’s list is another diverse set of stocks that are acting well. Our Top Pick is Entegris (ENTG), where an upcoming merger (and a uptick in the chip group) has investors piling in.

Stock Name	Price	Buy Range	Loss Limit
Boeing (BA)	432.22	382-395	347-352
Cree, Inc. (CREE)	67.96	48-50.5	44-45
CyberArk (CYBR)	111.74	83.5-86.5	75.5-77.5
Elastic (ESTC)	86.17	84-87	76-78
Entegris (ENTG)	48.08	32-34	28.5-29.5
ServiceNow (NOW)	341.86	218-226	199-203
Smartsheet (SMAR)	44.12	30-32	26.5-28
Spirit Airlines (SAVE)	57.03	60-63	55-56.5
Woodward (WWD)	111.91	87-90	80-82
Zscaler (ZS)	126.22	47-49.5	42.5-43.5

Current Market Outlook


It came on low volume and Independence Day made it just four days, but last week’s trading action was encouraging, with the major indexes generally holding key support early in the week and then bouncing nicely into the weekend. By our measures, the intermediate-term trend is still tilted up, and while there are fewer stocks hitting new highs than there were a few weeks back, there remain many stocks in good shape. With the improved evidence, we’re nudging our Market Monitor up a notch to 7; like we just wrote, last week was encouraging. But we also want to see how the indexes and leading stocks handle themselves now that big investors are back at their desks and earnings season gets underway.

This week’s list is again heavy on growth-oriented stocks, including a couple of newer names we haven’t seen before. Our Top Pick is Vertex Pharmaceuticals (VRTX), which has surged toward the top of an 11-month consolidation. We’re OK starting small and adding more if shares advance.

Stock Name	Price	Buy Range	Loss Limit
AeroVironment (AVAV)	80.48	68-71	61-63
Carrizo Oil & Gas (CRZO)	24.03	28-30	25-26
Dexcom (DXCM)	421.36	96-100	87-89
iRhythm Technologies (IRTC)	51.15	84-87	76-78
Lululemon Athletica (LULU)	304.69	122-128	112-115
Novocure (NVCR)	0.00	31.5-33	28.5-29.5
Shake Shack (SHAK)	92.08	62-65	55-57
Twitter (TWTR)	40.37	42-45	37.5-39.5
Vertex Pharmaceuticals (VRTX)	230.36	169-175	158-161
Yext Inc. (YEXT)	21.32	18.5-19.5	17-17.5

Current Market Outlook


Following the Brexit reaction, all of the major indexes are now decisively below their respective 50-day lines. Thus, we consider the intermediate-term trend to be down, which means it’s best to pare back. (We’ve knocked our Market Monitor down two notches this week.) It’s fine to hold your resilient, profitable performers (there are many stocks and sectors taking this selloff in stride), but you should honor all stops and loss limits and limit new buying to just small positions in strong stocks. The net result will be a higher cash position (around 50%, give or take, depending on what stocks you own and how you run your portfolio) and a handful of top performers in your portfolio. The next few days will be important—a quick snapback would be encouraging, but continued deterioration would have us advising an even more defensive posture. We’ll be watching.

This week’s list is a combination of defensive stocks, yield stocks, some precious metals and a couple of resilient growth ideas. Our Top Pick is Dollar Tree (DLTR), a defensive-type stock that should show excellent earnings growth thanks to last year’s game-changing buyout of Family Dollar.

Stock Name	Price	Buy Range	Loss Limit
Veeva Systems (VEEV)	180.23	32-34	29.5-30
Silver Wheaton (SLW)	0.00	20.5-21.5	19-19.5
SiteOne Landscape Supply (SITE)	98.49	31.5-33	28-28.5
Royal Gold, Inc. (RGLD)	129.66	67-69	61-63
Jack in the Box (JACK)	0.00	82-84.5	77-78
Gigamon (GIMO)	0.00	33-35	30-31
Dollar Tree (DLTR)	0.00	89-92	84-85
Communication Sales & Leasing (CSAL)	0.00	26-27.5	24-24.5
Boardwalk Pipeline Partners (BWP)	0.00	16.5-17.5	15.5-16
Align Technology (ALGN)	316.20	75.5-77.5	72-73

Current Market Outlook


Last week didn’t see much net change in the major indexes, but volatility has surged, with big swings up and down based on the news of the day. Overall, not much has changed—some stocks and sectors are acting well, but many others are chopping around and some (like MLPs) are literally crashing. By our measures, the market’s trends are still pointed up, but it’s close. All in all, we’re sticking with a relatively neutral stance, meaning we’re holding our top performers, but also holding some cash and being very selective on the buy side. And if something breaks down or trips its stop, it should be jettisoned quickly.

This week’s list continues with the bigger-cap, growth-oriented theme that’s been present for the past few weeks. Our Top Pick is Ulta Beauty (ULTA), which just gapped up to new highs after three months of rest following a great earnings report. Try to buy on dips.

Stock Name	Price	Buy Range	Loss Limit
Weibo (WB)	98.16	18-19	16-17
Western Alliance (WAL)	0.00	36.5-38	34.5-35
Ulta Beauty (ULTA)	331.95	180-184	169-170
Palo Alto Networks (PANW)	236.92	188-193	172-174
Nevro Corp. (NVRO)	0.00	58-62	52-54
Netflix, Inc. (NFLX)	423.92	123-127	113-115
Southwest Airlines (LUV)	0.00	48-50	44-45
Jabil Inc. (JBL)	41.50	24.5-26	23-23.5
Alibaba (BABA)	254.81	82-85	76-77
Broadcom Limited (AVGO)	266.26	142-146	132-134

Current Market Outlook


Trend following is our preferred method of market timing for two major reasons: If you follow the system, you’re guaranteed never to remain heavily invested in serious downtrend, and you’re also guaranteed never to miss out on a major uptrend. We’ve seen that play out in recent months—our Market Monitor shifted to neutral in mid-November and to bearish at the start of January, and we continue to advise a defensive stance as the market remains under pressure. We do think stocks could snap back some in the short-term, partially because the broad market isn’t in nearly as bad shape as it was on January 20, when the indexes initially dipped to these levels. But, bounce or not, it’s best to stick with the system, which means remaining defensive until the intermediate-term trend turns up.

This week’s list is a hodgepodge of stocks and sectors, but we feel many can do well once the market finds its footing. Our Top Pick is Michael Kors (KORS), which, after a multi-month bottoming effort, reacted well to earnings last week as results weren’t as bad as feared. The stock is dirt cheap, too.

Stock Name	Price	Buy Range	Loss Limit
Vantiv (VNTV)	0.00	43.5-45.5	41-42
Vulcan Materials Company (VMC)	137.10	86.5-90	81-82
Super Micro Computer (SMCI)	0.00	29-31	26-27
PayPal (PYPL)	147.00	32-34	29-29.5
Universal Display (OLED)	187.54	40-43	37-38
Newmont Mining (NEM)	57.31	23.5-25	21.5-22
Mattel, Inc. (MAT)	0.00	30-31	28-28.5
Michael Kors Holdings Limited (KORS)	73.22	47.5-50.5	43-44
First Solar (FSLR)	83.74	62-64	57.5-58
Agnico Eagle Mines (AEM)	79.05	31-33	28-28.5

Current Market Outlook


The market has made a little upside push during the past week or two, but net-net, most indexes are up just a smidgen during the past seven weeks. That sideways trading has contained most stocks and sectors, too, as they chop around with a slight upward bias. Even so, the intermediate- and longer-term trends are up, so the odds continue to favor the next major move being up. And we’re encouraged by both the number of positive earnings reactions we’ve seen, as well as the action of those stocks after they gap up—most have traded constructively post-earnings with no selling pressures coming in even after they ramp. All told, we’re still mostly positive, but we’ll keep our Market Monitor at a level 7 (out of 10) until we see more than just the Nasdaq decisively push out of their recent trading ranges.

This week’s list has another batch of strong stocks, including many that have recently reacted well to earnings. Our Top Pick is a tough call, but we’ll go with Ally Financial (ALLY), which just exploded higher on earnings after years in the market’s doghouse. It looks to be just starting its run.

Stock Name	Price	Buy Range	Loss Limit
Ally Financial (ALLY)	30.44	21.5-23	20-21
Century Aluminum Co. (CENX)	17.24	14-15	12.5-13
Essent Group (ESNT)	0.00	34-36	31.5-32.5
Exelixis (EXEL)	27.35	18.5-19.5	17-17.5
Olin Corp. (OLN)	0.00	28.5-30	26-27
Symantec Corporation (SYMC)	0.00	26.5-28	25-25.5
Teradyne (TER)	82.83	27-28.5	25-26
Tesla, Inc. (TSLA)	818.87	247-256	225-229
Texas Capital Bancshares (TCBI)	0.00	82-86	76-78
Yandex (YNDX)	0.00	22-23	20-21

Current Market Outlook


On an intermediate-term basis, the overall market remains stuck in the middle—many areas are still looking ragged, and most major indexes are hanging around their 50-day moving averages. Our screens this weekend did reveal a number of solid five- to six-week setups among growth stocks, as well as lots of solid action in other areas that have recently come to life. If the market gets going from here, there should be plenty of stocks to jump on. We’re not opposed to buying small amounts of a couple of these potential leaders today, but until we see more than just a day or two of rallying, you should play things carefully. We have our Market Monitor at a level 6 (out of 10), and will simply let the market tell us (through its own action) whether the next big move is up or down.

In the meantime, we’re laser-focused on stocks that have either just blasted out of bases or uptrending stocks that have resisted the Nasdaq’s wobbles since early June. Our Top Pick is Medidata Solutions (MDSO), which remains in good shape after lifting from a two-year base in April. Keep positions small.

Stock Name	Price	Buy Range	Loss Limit
Alibaba (BABA)	254.81	138-144	125-130
Align Technology (ALGN)	316.20	145-150	135-137
American Airlines Group Inc. (AAL)	0.00	51-53	46-47.5
Exact Sciences (EXAS)	116.91	35-37	31.5-32.5
First Republic Bank (FRC)	0.00	100.5-103.5	96-96.5
Medidata Solutions (MDSO)	0.00	77-80	71-72
Puma Biotech (PBYI)	0.00	82.5-87	74-76
RingCentral (RNG)	238.73	35.5-37.5	33-34
Tesoro (TSO)	0.00	92-95	87-88
WellCare Health Plans, Inc. (WCG)	271.83	177-181	166-168

The market continues to thrive as we enter the final month of 2023 – and Cabot Stock of the Week stocks are thriving along with it! A pullback in the coming days and perhaps weeks would make sense on the heels of the market’s banner November, but the long- and intermediate-term trajectory appears up. The potential (likelihood?) that interest rates may have peaked is perhaps the biggest driving force behind the rally. And it’s a big catalyst propelling the stock that we’re adding today, a brand-new recommendation from Mike Cintolo in Cabot Growth Investor.

Details inside.

Thank you for subscribing to the Cabot Turnaround Letter. We hope you enjoy reading the November 2023 issue.

Much of the art of finding interesting turnaround stocks is looking at catalysts, tracking management changes and searching through lists of out-of-favor companies. Sometimes, however, good ideas can be found closer to home – literally – by looking through the roster of public companies in one’s home state. We discuss five turnarounds underway in our home state of Massachusetts.

Despite near-record gold prices, shares of gold producers remain depressed. We discuss two attractive companies. Our Buy recommendation this month is Agnico Eagle Mines Ltd (AEM), a premier gold mining company selling at a discounted price.

Please feel free to send me your questions and comments. This investment letter is written for you. A great way to get more out of your letter is to let me know what you are looking for.